Saga in 'exclusive' sale talks with insurtech over Acromas underwriting arm


Over-50s specialist Saga has confirmed that it is in exclusive discussions with Australian insurtech Open to sell its insurance arm Acromas.

Saga had confirmed at the end of January that it was seeking a buyer for its underwriting arm.

Following a story on Sky News Saga released a statement to the London Stock Exchange today. It read: “Saga plc notes recent media coverage about the potential sale of Acromas Insurance Company Limited, the underwriter that is part of its wider insurance business, and confirms that it is in exclusive discussions with Open Insurance Technologies Pty Ltd regarding a possible sale of this business.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options


Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

Interview: Addept Group managing director Richard Finan

Addept MD Richard Finan gives Insurance Age the lowdown on his return to the market; his thoughts on changes to the MGA market in the wake of Consumer Duty; and the challenges of creating ancillary products in a post-FCA GAP intervention world.

Government starts discount rate review

The Ministry of Justice has confirmed the start of the 2024 review of the personal injury discount rate in England and Wales with a decision due no later than 11 January 2025.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: